Biochemical and Functional Characterization of Plasma Derived Human Celestrase 1

IF 0.5 Q4 HEMATOLOGY
Sheetal Dolia, Sachin Verma, Suma Ray
{"title":"Biochemical and Functional Characterization of Plasma Derived Human Celestrase 1","authors":"Sheetal Dolia, Sachin Verma, Suma Ray","doi":"10.1177/26348535231225317","DOIUrl":null,"url":null,"abstract":"C1-esterase inhibitor (C1-INH) is a protein derived from fresh frozen human plasma and is widely used in the treatment of Hereditary Angioedema. C1-INH product must have high purity with preserved functionality. The aim of the study was to perform extensive characterization of human C1-esterase inhibitor (Celestrase 1) with special emphasis on functionality of the protein by different mechanisms along with its purity and structural elucidation. Comparative study. This study describes the purification and characterization of an economically viable, highly pure and efficient human plasma-derived C1-INH prepared from cryopoor plasma by combination of chromatography steps, capable of removing protein contaminants. The purification process includes two orthogonal virus clearance steps -solvent detergent and virus retentive filtration and further, characterized by various biochemical and functional assays along with other commercially available entities. The developed process yields 0.75  ±  0.1 vials of C1-INH /L of cryopoor plasma with 44.4  ±  3.6% overall process recovery. Celestrase 1 shows comparability with an existing market comparator, with respect to its purity by different methods. Celestrase 1 proved its functionality in binding irreversibly to the complement protein by classical pathway of the complement system and in the Kallikrein system. Additionally, the antigen-to-biologic activity ratio an indicative of the functionality for Celestrase 1 (0.94) was found comparable to market comparator (0.79). Identity of the product was confirmed by Western blot analysis. The structural analysis of Celestrase 1 was found to be similar to market comparator and exists predominantly in α-helix secondary structure by Far UV Circular Dichroism (CD). For the treatment of Hereditary Angioedema (HAE), the current study presents a pure, safe, and functionally efficient product that can meet the therapeutic needs of patients deficient in C1-INH.","PeriodicalId":29816,"journal":{"name":"Plasmatology","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasmatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26348535231225317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

C1-esterase inhibitor (C1-INH) is a protein derived from fresh frozen human plasma and is widely used in the treatment of Hereditary Angioedema. C1-INH product must have high purity with preserved functionality. The aim of the study was to perform extensive characterization of human C1-esterase inhibitor (Celestrase 1) with special emphasis on functionality of the protein by different mechanisms along with its purity and structural elucidation. Comparative study. This study describes the purification and characterization of an economically viable, highly pure and efficient human plasma-derived C1-INH prepared from cryopoor plasma by combination of chromatography steps, capable of removing protein contaminants. The purification process includes two orthogonal virus clearance steps -solvent detergent and virus retentive filtration and further, characterized by various biochemical and functional assays along with other commercially available entities. The developed process yields 0.75  ±  0.1 vials of C1-INH /L of cryopoor plasma with 44.4  ±  3.6% overall process recovery. Celestrase 1 shows comparability with an existing market comparator, with respect to its purity by different methods. Celestrase 1 proved its functionality in binding irreversibly to the complement protein by classical pathway of the complement system and in the Kallikrein system. Additionally, the antigen-to-biologic activity ratio an indicative of the functionality for Celestrase 1 (0.94) was found comparable to market comparator (0.79). Identity of the product was confirmed by Western blot analysis. The structural analysis of Celestrase 1 was found to be similar to market comparator and exists predominantly in α-helix secondary structure by Far UV Circular Dichroism (CD). For the treatment of Hereditary Angioedema (HAE), the current study presents a pure, safe, and functionally efficient product that can meet the therapeutic needs of patients deficient in C1-INH.
血浆衍生的人 Celestrase 1 的生化和功能特性分析
C1-esterase 抑制剂(C1-INH)是一种提取自新鲜冷冻人血浆的蛋白质,广泛用于治疗遗传性血管性水肿。C1-INH 产品必须具有高纯度并保留其功能性。这项研究的目的是对人 C1-酯酶抑制剂(Celestrase 1)进行广泛的表征,特别强调该蛋白质通过不同机制发挥的功能以及它的纯度和结构阐明。比较研究。本研究介绍了一种经济可行、高纯度和高效率的人血浆衍生 C1-INH 的纯化和特性分析,该 C1-INH 由低温血浆制备而成,结合了色谱步骤,能够去除蛋白质杂质。纯化过程包括两个正交的病毒清除步骤--溶剂洗涤和病毒保留过滤。所开发的工艺可获得 0.75 ± 0.1 瓶/升低温血浆的 C1-INH,总体工艺回收率为 44.4 ± 3.6%。Celestrase 1 通过不同的方法显示出其纯度与市场上现有的参照物具有可比性。Celestrase 1 通过补体系统的经典途径和 Kallikrein 系统证明了其与补体蛋白不可逆结合的功能。此外,表明 Celestrase 1 功能的抗原生物活性比(0.94)与市场上的同类产品(0.79)相当。通过 Western 印迹分析确认了产品的身份。通过远紫外光圆二色性(CD)分析,发现 Celestrase 1 的结构与市场上的同类产品相似,主要存在于 α-螺旋二级结构中。对于遗传性血管性水肿(HAE)的治疗,目前的研究提出了一种纯净、安全、功能高效的产品,可以满足 C1-INH 缺乏患者的治疗需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Plasmatology
Plasmatology HEMATOLOGY-
CiteScore
1.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信